Therapeutic Potential of Janus-Activated Kinase-2 Inhibitors for the Management of Myelofibrosis
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-2836
Full Text
Open PDFAbstract
Available in full text
Date
March 9, 2010
Authors
Publisher
American Association for Cancer Research (AACR)